Cyteir Therapeutics, Inc.
USD3.02
-0.07 (-2.27%)
CEO
Markus F. Renschler
IPO Date
2021-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.03
Prev. Close
$3.09
Day Low
$3.00
Day High
$3.09
52W Low
$1.65
52W High
$3.19
Market Cap
$0.11B
Volume
1.01M
| 113,777 |
| $3.01 |
| 19 Mar 2024 | Leonard Braden Michael | 10 percent owner | Disposed | 0 | $0.00 |
| 19 Mar 2024 | Leonard Braden Michael | 10 percent owner | Disposed | 0 | $0.00 |
| 5 Mar 2024 | Gaiero David G | Chief Financial Officer | M-Exempt | Acquired | 2,373 | $1.69 |
| 5 Mar 2024 | Gaiero David G | Chief Financial Officer | M-Exempt | Acquired | 4,746 | $1.69 |
| 5 Mar 2024 | Gaiero David G | Chief Financial Officer | M-Exempt | Acquired | 3,239 | $1.68 |
| 5 Mar 2024 | Gaiero David G | Chief Financial Officer | M-Exempt | Disposed | 4,746 | $1.69 |
| 5 Mar 2024 | Gaiero David G | Chief Financial Officer | M-Exempt | Disposed | 2,373 | $1.69 |
| 5 Mar 2024 | Gaiero David G | Chief Financial Officer | M-Exempt | Disposed | 3,239 | $1.68 |